查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1811041

2025年全球外科止血市場報告

Surgical Hemostats Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年外科止血鉗市場規模將強勁成長，到2029年將達到50.9億美元，複合年成長率為6.6%。預測期內的成長預計將受到以下因素的推動：對先進傷口縫合產品的需求不斷成長、門診手術中心的擴張、對可生物分解止血鉗的偏好日益成長、伴隨止血鉗的使用日益增多，以及需要手術干預的文明病的患病率不斷上升。這段時期的主要趨勢包括可吸收止血鉗的技術進步、其與機器人手術的整合、下一代止血鉗配方的開發、其與智慧手術設備的整合以及植物性止血鉗的技術創新。

預計創傷病例的增加將在不久的將來推動外科止血鉗市場的成長。創傷是指痛苦或有害事件造成的身體傷害或心理衝擊，會影響個人的身心健康。創傷病例的增加主要是由於交通事故的急劇增加，交通事故會導致嚴重損傷，需要立即就醫。外科止血鉗能夠快速有效地控制創傷期間的出血，減少出血量並穩定患者病情，幫助他們獲得進一步的治療。例如，根據威斯康辛州衛生服務部的數據，2023 年與攻擊相關的創傷病例與 2022 年相比增加了 3%，從 1,544 例增加到 1,584 例。因此，創傷案例的增加正在刺激外科止血鉗市場的擴張。

手術止血鉗市場的主要企業正在使用可吸收氧化再生纖維素 (ORC) 等創新材料開發先進產品，以改善出血控制並促進創傷治療。可吸收氧化再生纖維素是一種用於手術止血鉗的可生物分解的植物來源材料。它透過在傷口部位建立物理屏障並促進血塊形成來止血。 2022 年 2 月，印度醫療設備製造商 Futura Surgicare Pvt. Ltd. 推出了 Hemostax，這是一種先進的可吸收 ORC 止血鉗，旨在有效控制術中出血。本產品在 1.5 分鐘內開始止血，並在 2 至 5 分鐘內完成其效果。它會在 1 至 2 週內完全吸收，無需移除。 Hemostax 使用方便，適用於各種手術部位，無毒性、生物相容性好，並具有針對抗藥性細菌的抗菌特性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球外科止血鉗市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球外科止血鉗市場：成長率分析
  • 全球外科止血鉗市場表現：規模與成長，2019-2024
  • 全球外科止血鉗市場預測：規模與成長，2024-2029，2034
  • 全球外科止血鉗：總目標市場（TAM）

第6章 市場細分

  • 全球外科止血鉗市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 局部凝血酶止血劑
  • 流體止血材料
  • 膠原蛋白基止血材料
  • 氧化再生纖維素止血材料
  • 明膠基止血材料
  • 複合止血鉗
  • 其他
  • 全球外科止血劑市場：按配方、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 基質和凝膠止血劑
  • 海綿止血鉗
  • 床單和墊片止血鉗
  • 粉末止血劑
  • 全球外科止血鉗市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 神經外科
  • 整形外科
  • 心血管外科
  • 婦科手術
  • 創傷
  • 整形外科
  • 其他
  • 全球外科止血鉗市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他
  • 全球外科止血劑市場：局部凝血酶類止血劑細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 基於人類凝血酶的止血劑
  • 牛凝血酶類止血劑
  • 重組凝血酶止血劑
  • 劑型：凝膠、噴霧、粉末、海綿
  • 全球外科止血鉗市場：流動止血鉗細分市場、類型、性能及預測（2019-2024、2024-2029、2034）
  • 含凝血酶的明膠基質
  • 膠原蛋白基流動性
  • 合成聚合物基流動材料
  • 全球外科止血劑市場：膠原蛋白類止血劑細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 微纖維膠原膠原蛋白
  • 不織布膠原蛋白墊片
  • 膠原蛋白蛋白絨或片
  • 全球外科止血劑市場：氧化再生纖維素止血劑細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 編織氧化再生纖維素纖維
  • 不不織布氧化再生纖維素墊片
  • 含添加劑的氧化再生纖維素
  • 全球外科止血劑市場：明膠基止血劑細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 明膠海綿
  • 明膠粉
  • 含有凝血酶的明膠泡沫
  • 全球外科止血鉗市場：複合止血鉗細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 明膠+凝血酶
  • 膠原蛋白+凝血酶
  • 氧化再生纖維素+凝血酶
  • 全球外科止血鉗市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 幾丁聚醣基止血材料
  • 高嶺土基止血材料
  • 合成胜肽止血材料
  • 植物來源藥物

第7章 區域和國家分析

  • 全球外科止血鉗市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球外科止血鉗市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 外科止血鉗市場：競爭格局
  • 外科止血鉗市場：公司簡介
    • Johnson And Johnson Services Inc.
    • Medtronic plc
    • Becton Dickinson And Company
    • Stryker Corporation
    • Baxter International Inc.

第31章：其他領先和創新企業

  • Teleflex Corporation
  • Integra LifeSciences Holdings Corporation
  • GELITA MEDICAL GmbH
  • B. Braun Melsungen AG
  • Advanced Medical Solutions Group plc
  • Axio Biosolutions Pvt. Ltd.
  • Marine Polymer Technologies Inc
  • Biom'up USA Inc
  • Lotus Surgicals Pvt. Ltd
  • Hemostasis LLC
  • Biocer Entwicklungs-GmbH
  • CuraMedical BV
  • EndoClot Plus Inc
  • Starch Medical Inc
  • Tricol Biomedical Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年外科止血鉗市場：提供新機會的國家
  • 2029年外科止血鉗市場：細分市場帶來新機會
  • 2029年外科止血鉗市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37145

Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.

The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. The surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical hemostats market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. Growth during the historic period can be attributed to the rising number of surgical procedures, an increase in trauma and accident cases, a growing elderly population, greater adoption of minimally invasive surgical techniques, and a higher prevalence of chronic diseases.

The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. Growth in the forecast period is expected to be driven by increasing demand for advanced wound closure products, the expansion of ambulatory surgical centers, a growing preference for biodegradable hemostats, increased use of combination hemostatic agents, and a rising incidence of lifestyle-related diseases requiring surgical intervention. Key trends during this period include technological advancements in absorbable hemostats, integration of technology in robotic surgeries, development of next-generation hemostatic formulations, incorporation with smart surgical devices, and innovations in plant-based hemostatic products.

The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.

Leading companies in the surgical hemostats market are developing advanced products using innovative materials such as absorbable oxidized regenerated cellulose (ORC) to improve bleeding control and accelerate wound healing. Absorbable oxidized regenerated cellulose is a biodegradable, plant-derived material used in surgical hemostats to stop bleeding by creating a physical barrier and encouraging clot formation at the wound site. In February 2022, Futura Surgicare Pvt. Ltd., an India-based medical device manufacturer, introduced Hemostax, an advanced absorbable ORC hemostat designed for effective intraoperative bleeding control. This product initiates hemostasis within 1.5 minutes and completes its effect in 2 to 5 minutes. It is fully absorbed within 1 to 2 weeks, eliminating the need for removal. Hemostax is user-friendly, adapts well to various surgical sites, is non-toxic, biocompatible, and possesses antibacterial properties against drug-resistant bacteria.

In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.

Major players in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom'up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc.

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in surgical hemostats report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Surgical Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Topical Thrombin-Based Hemostats; Flowable Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Gelatin-Based Hemostats; Combination Hemostats; Other Product Types
  • 2) By Formulation: Matrix And Gel Hemostats; Sponge Hemostats; Sheet And Pad Hemostats; Powder Hemostats
  • 3) By Application: Neurological Surgery; Orthopedic Surgery; Cardiovascular Surgery; Gynecological Surgery; Trauma; Plastic Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats; Bovine Thrombin-Based Hemostats; Recombinant Thrombin-Based Hemostats; Formulations Gel, Spray, Powder, Sponge
  • 2) By Flowable Hemostats: Gelatin Matrix With Thrombin; Collagen-Based Flowables; Synthetic Polymer-Based Flowables
  • 3) By Collagen-Based Hemostats: Microfibrillar Collagen; Nonwoven Collagen Pads; Collagen Fleece Or Sheets
  • 4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric; Non-woven Oxidized Regenerated Cellulose Pads; Oxidized Regenerated Cellulose With Additives
  • 5) By Gelatin-Based Hemostats: Gelatin Sponge; Gelatin Powder; Gelatin Foam With Thrombin
  • 6) By Combination Hemostats: Gelatin + Thrombin; Collagen + Thrombin; Oxidized Regenerated Cellulose + Thrombin
  • 7) By Other Product Types: Chitosan-Based Hemostats; Kaolin-Based Hemostats; Synthetic Peptide Hemostats; Plant-Derived Agents
  • Companies Mentioned: Johnson And Johnson Services Inc.; Medtronic plc; Becton Dickinson And Company; Stryker Corporation; Baxter International Inc.; Teleflex Corporation; Integra LifeSciences Holdings Corporation.; GELITA MEDICAL GmbH; B. Braun Melsungen AG; Advanced Medical Solutions Group plc; Axio Biosolutions Pvt. Ltd.; Marine Polymer Technologies Inc; Biom'up USA Inc; Lotus Surgicals Pvt. Ltd; Hemostasis LLC; Biocer Entwicklungs-GmbH; CuraMedical BV; EndoClot Plus Inc; Starch Medical Inc; Tricol Biomedical Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Surgical Hemostats Market Characteristics

3. Surgical Hemostats Market Trends And Strategies

4. Surgical Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Surgical Hemostats Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Surgical Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Surgical Hemostats Market Growth Rate Analysis
  • 5.4. Global Surgical Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Surgical Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Surgical Hemostats Total Addressable Market (TAM)

6. Surgical Hemostats Market Segmentation

  • 6.1. Global Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Thrombin-Based Hemostats
  • Flowable Hemostats
  • Collagen-Based Hemostats
  • Oxidized Regenerated Cellulose-Based Hemostats
  • Gelatin-Based Hemostats
  • Combination Hemostats
  • Other Product Types
  • 6.2. Global Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Matrix And Gel Hemostats
  • Sponge Hemostats
  • Sheet And Pad Hemostats
  • Powder Hemostats
  • 6.3. Global Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurological Surgery
  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Trauma
  • Plastic Surgery
  • Other Applications
  • 6.4. Global Surgical Hemostats Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End-Users
  • 6.5. Global Surgical Hemostats Market, Sub-Segmentation Of Topical Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Thrombin-Based Hemostats
  • Bovine Thrombin-Based Hemostats
  • Recombinant Thrombin-Based Hemostats
  • Formulations Gel, Spray, Powder, Sponge
  • 6.6. Global Surgical Hemostats Market, Sub-Segmentation Of Flowable Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin Matrix With Thrombin
  • Collagen-Based Flowables
  • Synthetic Polymer-Based Flowables
  • 6.7. Global Surgical Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfibrillar Collagen
  • Nonwoven Collagen Pads
  • Collagen Fleece Or Sheets
  • 6.8. Global Surgical Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Woven Oxidized Regenerated Cellulose Fabric
  • Non-woven Oxidized Regenerated Cellulose Pads
  • Oxidized Regenerated Cellulose With Additives
  • 6.9. Global Surgical Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin Sponge
  • Gelatin Powder
  • Gelatin Foam With Thrombin
  • 6.10. Global Surgical Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin + Thrombin
  • Collagen + Thrombin
  • Oxidized Regenerated Cellulose + Thrombin
  • 6.11. Global Surgical Hemostats Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chitosan-Based Hemostats
  • Kaolin-Based Hemostats
  • Synthetic Peptide Hemostats
  • Plant-Derived Agents

7. Surgical Hemostats Market Regional And Country Analysis

  • 7.1. Global Surgical Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Surgical Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Surgical Hemostats Market

  • 8.1. Asia-Pacific Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Surgical Hemostats Market

  • 9.1. China Surgical Hemostats Market Overview
  • 9.2. China Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Surgical Hemostats Market

  • 10.1. India Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Surgical Hemostats Market

  • 11.1. Japan Surgical Hemostats Market Overview
  • 11.2. Japan Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Surgical Hemostats Market

  • 12.1. Australia Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Surgical Hemostats Market

  • 13.1. Indonesia Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Surgical Hemostats Market

  • 14.1. South Korea Surgical Hemostats Market Overview
  • 14.2. South Korea Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Surgical Hemostats Market

  • 15.1. Western Europe Surgical Hemostats Market Overview
  • 15.2. Western Europe Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Surgical Hemostats Market

  • 16.1. UK Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Surgical Hemostats Market

  • 17.1. Germany Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Surgical Hemostats Market

  • 18.1. France Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Surgical Hemostats Market

  • 19.1. Italy Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Surgical Hemostats Market

  • 20.1. Spain Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Surgical Hemostats Market

  • 21.1. Eastern Europe Surgical Hemostats Market Overview
  • 21.2. Eastern Europe Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Surgical Hemostats Market

  • 22.1. Russia Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Surgical Hemostats Market

  • 23.1. North America Surgical Hemostats Market Overview
  • 23.2. North America Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Surgical Hemostats Market

  • 24.1. USA Surgical Hemostats Market Overview
  • 24.2. USA Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Surgical Hemostats Market

  • 25.1. Canada Surgical Hemostats Market Overview
  • 25.2. Canada Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Surgical Hemostats Market

  • 26.1. South America Surgical Hemostats Market Overview
  • 26.2. South America Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Surgical Hemostats Market

  • 27.1. Brazil Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Surgical Hemostats Market

  • 28.1. Middle East Surgical Hemostats Market Overview
  • 28.2. Middle East Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Surgical Hemostats Market

  • 29.1. Africa Surgical Hemostats Market Overview
  • 29.2. Africa Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Surgical Hemostats Market Competitive Landscape And Company Profiles

  • 30.1. Surgical Hemostats Market Competitive Landscape
  • 30.2. Surgical Hemostats Market Company Profiles
    • 30.2.1. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Surgical Hemostats Market Other Major And Innovative Companies

  • 31.1. Teleflex Corporation
  • 31.2. Integra LifeSciences Holdings Corporation.
  • 31.3. GELITA MEDICAL GmbH
  • 31.4. B. Braun Melsungen AG
  • 31.5. Advanced Medical Solutions Group plc
  • 31.6. Axio Biosolutions Pvt. Ltd.
  • 31.7. Marine Polymer Technologies Inc
  • 31.8. Biom'up USA Inc
  • 31.9. Lotus Surgicals Pvt. Ltd
  • 31.10. Hemostasis LLC
  • 31.11. Biocer Entwicklungs-GmbH
  • 31.12. CuraMedical BV
  • 31.13. EndoClot Plus Inc
  • 31.14. Starch Medical Inc
  • 31.15. Tricol Biomedical Inc

32. Global Surgical Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Surgical Hemostats Market

34. Recent Developments In The Surgical Hemostats Market

35. Surgical Hemostats Market High Potential Countries, Segments and Strategies

  • 35.1 Surgical Hemostats Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Surgical Hemostats Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Surgical Hemostats Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer